Table 1

Basic and clinical characteristics at baseline of the 22 patients

CharacteristicsValue
Male/female14/8
Age (years), mean (range)43.3 (21–61)
Disease duration psoriasis (years), median (range)12.7 (1–53)
Disease duration PsA (years), median (range)6.3 (1–18)
Clinical phenotype: PA/OA/DIP915/6/1
Concomitant MTX use, n (%)12 (55)
MTX dose (mg/week), median (range)17.5 (10–25)
DAS28, mean (SEM)4.92 (0.25)
PASI, median (IQR)5.7 (1.5–7.0)
ESR (mm/h), median (IQR)17.5 (7.8–31)
CRP (mg/l), median (IQR)6.2 (2.6–25.7)
  • CRP, C-reactive protein; DAS28, Disease Activity Score in 28 joints; DIP, distal interphalangeal joint; ESR, erythrocyte sedimentation rate; IQR, interquartile range; MTX, methotrexate; OA, oligoarticular; PA, polyarticular; PASI, Psoriasis Area and Severity Index; PsA, psoriatic arthritis.